Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Vulvovaginal candidiasis

Vulvovaginal candidiasis

Part of Fungal infection

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Vulvovaginal candidiasis

14 trials tracked for Vulvovaginal candidiasis: 4 in phase 3 or 4 and 2 with published results. The most-cited published study has 35 citations.

14Trials tracked
4Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 2 Phase 3 2 Phase 2 4 Phase 1 1 Other / NA 5
  1. Phase 4 Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis Completed · 35 cited
  2. Phase 4 Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis Completed · 24 cited
  3. Phase 3 Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis Completed
  4. Phase 3 The Study Of Fluconazole For Vulvovaginal Candidiasis Completed
  5. Phase 2 Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis Completed
  6. Phase 2 A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection) Completed
Show 8 more trials
  1. Phase 2 Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment Completed
  2. Phase 2 Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) Completed
  3. Phase 1 Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp Completed
  4. N/A A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations Completed
  5. N/A Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis Completed
  6. N/A Clinical Performance of a Vaginal Pessary (pHyph) in Vulvovaginal Candidiasis Completed
  7. N/A Monthly Itraconazole Versus Classic Homeopathy for Treatment of Recurrent Vulvovaginal Candidiasis (RVVC) Completed
  8. N/A Clinical Performance of the Gedea Pessary in Adult Women With Vulvovaginal Candidiasis Completed

Showing the 14 most-cited and recently-updated of 14 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Review of antifungal options for vulvovaginal candidiasis in women of reproductive age
Infectious Disease Sys. Review
Review of antifungal options for vulvovaginal candidiasis in women of reproductive age New Treatments for a Common Yeast Infection That Keeps Coming Back
This review examines antifungal treatments for vulvovaginal candidiasis in women of reproductive age. The authors discuss azoles, boric acid…
If you have a yeast infection that won't go away with standard creams, new oral medications and even boric acid are changing how doctors tre…
Frontiers May 15, 2026

Research across Fungal infection

Related studies from across the Fungal infection family.

Secondary analysis of 342 sepsis patients reveals limited diagnostic utility for serum biomarkers in invasive candidiasis diagnosis
Emergency Medicine RCT
Secondary analysis of 342 sepsis patients reveals limited diagnostic utility for serum biomarkers in invasive candidiasis diagnosis Doctors tested blood markers to find infection signs in sick patients quickly
Analysis of 342 sepsis patients across German ICUs shows serum antigens rise in infection, but antibodies do not. Single biomarkers offer mo…
A study of 342 sick patients found that one specific blood test works best for spotting dangerous infections. Combining multiple tests did n…
May 13, 2026
Pooled analysis review of rezafungin versus caspofungin for candidemia and invasive candidiasis
Drug Pipeline
Pooled analysis review of rezafungin versus caspofungin for candidemia and invasive candidiasis Weekly Drug Clears Blood Fungus Faster Than Daily Treatment
This review synthesizes a pooled analysis of two randomized trials evaluating rezafungin versus caspofungin in adults with candidemia or inv…
A new weekly medication clears blood infections just as well as daily shots, offering hope for shorter care.
Apr 19, 2026